Latest news

Thumbnail image for US regulators reject GSK’s Nucala for COPD

US regulators reject GSK’s Nucala for COPD

GlaxoSmithKline’s bid to expand the use of its biologic Nucala in the US to include patients with coronary pulmonary obstructive disorder (COPD) has hit a significant setback.

10th September 2018

Thumbnail image for Gov’t sees new tech as key to NHS success

Gov’t sees new tech as key to NHS success

The government has unveiled its ambition for the NHS to become “the most advanced health system in the world” through use of the “best innovations in new technology and artificial intelligence”.

7th September 2018

Thumbnail image for FDA extends review time for Roche’s Tecentriq/Avastin combo

FDA extends review time for Roche’s Tecentriq/Avastin combo

US regulators have extended the review period for Roche’s application to market Tecentriq in combination with Avastin, carboplatin and paclitaxel for first-line treatment of metastatic non-squamous non-small cell lung cancer (NSCLC).

6th September 2018

Thumbnail image for Teva drops development of laquinimod

Teva drops development of laquinimod

Teva Pharmaceutical Industries has decided not to pursue development of laquinimod, and has returned rights to the drug back to Swedish group Active Biotech.

6th September 2018

Previous  --   4 5 6 7 8 9 10 11 12 13   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download